Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00864240 · ClinicalTrials.gov registry record · Phase 1
The Dose-response "Pilot" Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects
A Phase 1 study, sponsored by Actavis.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT00864240 is a Phase 1 study that has completed, run by Actavis. The registered enrollment target is 15 participants.
The verdict
NCT00864240, a Phase 1 study, has completed, sponsored by Actavis.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
To determine the dose-response relationship for Clobex TM (clobetasol propionate) Lotion, 0.05%. This information will be used to estimate the ED50, D1, D2 parameters for use in a full bioequivalence study.
Interventions
- DRUG Clobex TM (Clobetasol) 0.05% Lotion, single exposure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2005-10 |
| Est. Completion | 2005-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00864240
The ClinicalTrials.gov registry entry for NCT00864240 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Actavis, which has 79 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Clobex TM (Clobetasol) 0.05% Lotion, single exposure is the first listed.
NCT00864240 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00864240 about?
NCT00864240 is a clinical study titled "The Dose-response "Pilot" Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects". To determine the dose-response relationship for Clobex TM (clobetasol propionate) Lotion, 0.05%. This information will be used to estimate the ED50, D1, D2 parameters for use in a full bioequivalence study.
What is the current status of trial NCT00864240?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2005-10. Estimated completion is 2005-10.
What interventions are being tested in trial NCT00864240?
The interventions under investigation include: Clobex TM (Clobetasol) 0.05% Lotion, single exposure (DRUG).
Who is sponsoring clinical trial NCT00864240?
This trial is sponsored by Actavis, which has 79 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.